Stand & Move at Work: A Group Randomized Trial
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Obesity
- Sponsor
- Arizona State University
- Enrollment
- 630
- Locations
- 2
- Primary Endpoint
- Mean Change in Light-intensity Physical Activity at Work From Baseline to 12 Months
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
A trial testing the efficacy of sit-stand workstations on decreasing sitting time and increasing light-intensity physical activity in samples of office worksites.
Detailed Description
With traditional approaches to increasing MVPA (moderate to vigorous physical activity) in the workplace being unsustainable due to the requirement of deliberate and dedicated time away from work, this group-randomized trial will test the efficacy of sit-stand workstations on decreasing sitting time and increasing light-intensity physical activity (LPA) in a highly generalizable sample of office worksites using a multi-level intervention with high potential for dissemination.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Worksite-level inclusion criteria:
- •Size: Small to moderate size worksite (20-60 employees)
- •Schedule: \>80% of employees full time
- •Occupation: Seated office work, primarily computer- and- telephone-based work, little movement or walking
- •Wellness environment: Not currently undergoing a wellness program aimed at increasing activity at work
- •Workstations: Willing to have sit-stand workstations installed at a worksite
- •Willing to be randomized: Willing to be randomized to either intervention conditions
- •Member-level inclusion criteria:
- •Age: 18 years and older
- •Health status: Generally good health and able to safely increase LPA and reduce sitting time
Exclusion Criteria
- •contraindication to prolonged standing at work
Outcomes
Primary Outcomes
Mean Change in Light-intensity Physical Activity at Work From Baseline to 12 Months
Time Frame: 1 year
Measured via 7d of activPAL accelerometry (value at 12 months minus value at baseline)
Mean Change in Sitting Time at Work From Baseline to 12 Months
Time Frame: 1 year
Measured via 7d of activPAL accelerometry (value at 12 months minus value at baseline)
Secondary Outcomes
- Clustered Metabolic Risk Score From Baseline to 12 Months(1 year)